Ocular adverse events in PD-1 and PD-L1 inhibitors

Ocular adverse events in PD-1 and PD-L1 inhibitors

Background Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye.Methods Two adverse event databases were retrospe...

Full description

Saved in:
Bibliographic Details
Main Authors: James Murray, Howard Streicher, Elad Sharon, LeAnne Young, Shanda Finnigan, H Nida Sen, Helen X Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e002119.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items